U.S. Physical (USPH) | Financial Analysis & Statements
U.S. Physical Therapy Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
202.7M
Gross Profit
40.1M
19.80%
Operating Income
22.0M
10.86%
Net Income
9.2M
4.53%
EPS (Diluted)
$-0.44
Balance Sheet Metrics
Total Assets
1.2B
Total Liabilities
433.8M
Shareholders Equity
770.2M
Debt to Equity
0.56
Cash Flow Metrics
Operating Cash Flow
20.6M
Free Cash Flow
21.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
U.S. Physical Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 781.0M | 671.3M | 604.8M | 553.1M | 495.0M |
| Cost of Goods Sold | 631.3M | 547.4M | 483.3M | 441.1M | 377.8M |
| Gross Profit | 149.7M | 123.9M | 121.5M | 112.0M | 117.2M |
| Gross Margin % | 19.2% | 18.5% | 20.1% | 20.3% | 23.7% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | 46.1M | 46.5M |
| Other Operating Expenses | 69.3M | 58.3M | 51.5M | 46.1M | 41.9M |
| Total Operating Expenses | 69.3M | 58.3M | 51.5M | 92.2M | 88.5M |
| Operating Income | 80.4M | 65.6M | 70.0M | 65.9M | 75.2M |
| Operating Margin % | 10.3% | 9.8% | 11.6% | 11.9% | 15.2% |
| Non-Operating Items | |||||
| Interest Income | 105.0K | 3.9M | 3.8M | 0 | 0 |
| Interest Expense | 9.5M | 8.0M | 9.3M | 5.8M | 942.0K |
| Other Non-Operating Income | 6.7M | -1.3M | -15.1M | -4.6M | -1.1M |
| Pre-tax Income | 77.8M | 60.2M | 49.4M | 55.6M | 73.2M |
| Income Tax | 19.8M | 14.6M | 12.2M | 12.2M | 15.3M |
| Effective Tax Rate % | 25.5% | 24.3% | 24.6% | 21.9% | 20.9% |
| Net Income | 58.0M | 45.6M | 37.2M | 43.4M | 57.9M |
| Net Margin % | 7.4% | 6.8% | 6.2% | 7.8% | 11.7% |
| Key Metrics | |||||
| EBITDA | 104.9M | 89.6M | 90.8M | 82.7M | 88.4M |
| EPS (Basic) | $1.42 | $1.84 | $1.28 | $2.25 | $2.41 |
| EPS (Diluted) | $1.42 | $1.84 | $1.28 | $2.25 | $2.41 |
| Basic Shares Outstanding | 15175000 | 15064000 | 14188000 | 12985000 | 12898000 |
| Diluted Shares Outstanding | 15175000 | 15064000 | 14188000 | 12985000 | 12898000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
U.S. Physical Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 35.6M | 41.4M | 152.8M | 31.6M | 28.6M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 64.2M | 59.0M | 69.7M | 68.6M | 46.3M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 16.1M | 10.6M | 10.8M | 11.1M | 4.2M |
| Total Current Assets | 140.0M | 137.6M | 233.4M | 111.3M | 95.2M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 144.2M | 133.9M | 103.4M | 103.0M | 96.4M |
| Goodwill | 1.6B | 1.5B | 1.1B | 1.1B | 955.7M |
| Intangible Assets | 172.9M | 179.3M | 109.7M | 108.8M | 86.4M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 6.6M | 5.2M | 2.8M | 4.1M | 1.6M |
| Total Non-Current Assets | 1.1B | 1.0B | 763.9M | 746.9M | 654.3M |
| Total Assets | 1.2B | 1.2B | 997.2M | 858.2M | 749.4M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 6.1M | 5.9M | 3.9M | 6.5M | 6.5M |
| Short-term Debt | 52.0M | 50.8M | 42.9M | 41.6M | 31.3M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 139.0M | 116.3M | 102.2M | 85.5M | 83.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | 263.2M | 244.4M | 215.6M | 253.8M | 191.8M |
| Deferred Tax Liabilities | 28.4M | 29.5M | 24.8M | 21.3M | 14.4M |
| Other Non-Current Liabilities | 3.2M | 18.3M | 2.4M | 13.0M | 7.3M |
| Total Non-Current Liabilities | 294.8M | 292.1M | 242.8M | 288.1M | 213.5M |
| Total Liabilities | 433.8M | 408.4M | 345.0M | 373.6M | 297.0M |
| Equity | |||||
| Common Stock | 174.0K | 172.0K | 172.0K | 152.0K | 151.0K |
| Retained Earnings | 227.2M | 227.3M | 223.8M | 232.9M | 224.4M |
| Treasury Stock | 37.2M | 31.6M | 31.6M | 31.6M | 31.6M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 770.2M | 759.0M | 652.2M | 484.6M | 452.4M |
| Key Metrics | |||||
| Total Debt | 315.2M | 295.2M | 258.6M | 295.3M | 223.1M |
| Working Capital | 950.0K | 21.3M | 131.2M | 25.8M | 11.7M |
Balance Sheet Composition
U.S. Physical Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 58.0M | 45.6M | 37.2M | 43.4M | 57.9M |
| Depreciation & Amortization | 22.4M | 18.7M | 15.7M | 14.7M | 11.6M |
| Stock-Based Compensation | 8.3M | 7.8M | 7.2M | 7.3M | 7.9M |
| Working Capital Changes | -19.4M | -14.1M | -4.9M | -14.0M | -16.4M |
| Operating Cash Flow | 76.3M | 64.1M | 59.1M | 53.4M | 66.6M |
| Investing Activities | |||||
| Capital Expenditures | -14.1M | -9.2M | -9.3M | -8.2M | -8.2M |
| Acquisitions | -24.9M | -142.0M | -36.9M | -74.3M | -116.1M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -38.1M | -150.5M | -45.8M | -82.5M | -124.3M |
| Financing Activities | |||||
| Share Repurchases | -5.6M | - | - | - | - |
| Dividends Paid | -27.4M | -26.5M | -24.1M | -21.3M | -18.8M |
| Debt Issuance | 189.5M | 19.0M | 24.0M | 251.0M | 316.0M |
| Debt Repayment | -181.4M | -14.7M | -63.2M | -186.8M | -222.9M |
| Financing Cash Flow | -44.1M | -37.0M | 84.3M | 25.8M | 141.4M |
| Free Cash Flow | 61.0M | 65.8M | 72.7M | 50.3M | 68.2M |
| Net Change in Cash | -6.0M | -123.4M | 97.5M | -3.3M | 83.6M |
Cash Flow Trend
U.S. Physical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
52.65
Forward P/E
22.57
Price to Book
2.37
Price to Sales
1.47
PEG Ratio
-0.29
Profitability Ratios
Profit Margin
5.12%
Operating Margin
10.95%
Return on Equity
7.59%
Return on Assets
4.25%
Financial Health
Current Ratio
1.01
Debt to Equity
40.92
Beta
1.35
Per Share Data
EPS (TTM)
$1.42
Book Value per Share
$31.51
Revenue per Share
$50.96
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| USPH | 1.1B | 52.65 | 2.37 | 7.59% | 5.12% | 40.92 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Pediatrix Medical | 1.9B | 11.88 | 2.16 | 20.28% | 8.64% | 73.29 |
| Surgery Partners | 1.9B | 2,956.00 | 1.09 | 2.76% | -2.35% | 114.51 |
| Astrana Health | 1.9B | 73.30 | 2.12 | 4.49% | 0.71% | 193.10 |
Financial data is updated regularly. All figures are in the company's reporting currency.






